|
August 2000
Eliminating
blood transfusions: new aspects and perspectives
Spahn DR and Casutt M. Anesthesiology 2000;93:242-55
[see abstract below]
Return to the Current Literature Review Front Page
Commentary by Katherine
Grichnik, M.D.
This very well written review article about the consequences of allogeneic
blood transfusion also includes a discussion of methods to reduce and/or
eliminate the need for allogeneic blood transfusion. The article is written
by experts in this field and offers practical insights and suggestions.
The first part of the article reviews
the efficacy, adverse effects, and costs of allogeneic blood transfusions.
The efficacy of transfusion to a certain hemoglobin (Hb) concentration
is questioned and results are presented in which ICU patients may benefit
from fewer transfusions with respect to morbidity and mortality. The adverse
effects of transmission of infectious diseases, immunomodulation and transfusion-related
acute lung injury are reviewed. The costs are discussed as the direct
red blood cell (RBC) costs (costs associated with obtaining and infusing
RBCs) and the indirect costs of additional treatments and/or prolonged
hospitalization related to allogeneic blood transfusions.
The major part of the review is
a discussion of alternatives to allogeneic blood transfusions. Included
are presentations of 1) preoperative autologous donation, 2) preoperative
use of erythropoietin, 3) acute normovolemic hemodilution, 4) intraoperative
cell salvage and retransfusion, 5) pharmacologic treatment, 6) anesthesia
technique, 7) surgical technique, 8) acceptance of minimal Hb levels and
transfusion algorithms based on coagulation monitoring, 9) artificial
Hb carriers, and 10) combination of different blood conservation strategies.
Autologous donation is presented
as a balance of cost, safety and convenience for the patient with the
reasonable question discussed of different transfusion triggers for an
autologous RBC unit versus an allogeneic RBC unit. The efficacy of preoperative
erythropoietin use with an analysis of its side effects, use in high risk
patients and use in combination with acute normovolemic hemodilution (ANH)
presented.
ANH has been found to reduce allogeneic
blood transfusions in clinically relevant settings. The limits and safety
are briefly presented here but discussed further in the anesthesia technique
and acceptance of minimal Hb sections. The pros and cons of intraoperative
cell salvage and retransfusion is presented, including a warning about
the metabolic derangements and other problems which can occur with this
technique. The authors also present an alternative to the traditional
notion that cell salvage cannot be used for nonsterile fields and cancer
surgery.
Pharmacological treatment with
various antifibrinolytics is outlined. Anesthesia technique is discussed
in more detail with sections on maintaining normothermia, optimal fluid
replacement (including for use with ANH), hyperoxic ventilation and hypotensive
anesthesia. Brief mention is made of the importance of surgical technique
in the avoidance of allogeneic blood transfusions.
There is an in-depth discussion
on the acceptance of minimal Hb levels, with specific paragraphs on splanchnic
circulatory adequacy, cerebral blood flow adequacy, use with ANH, use
in various coronary and cardiac disease states, use in the elderly, and
what constitutes an adequate Hb level in the perioperative period. This
section then combines with the next section of transfusion algorithms
based on blood coagulation monitoring.
Artificial oxygen carriers are
not really discussed as these drugs are still undergoing clinical testing.
The paper ends with a brief summary of the efficacy of combining various
strategies to reduce the need for allogeneic blood transfusions.
In all, this review
is concise, easy to read and offers the challenge to implement therapies
to reduce blood transfusions in our practices.
 |
ABSTRACTS
Eliminating Blood Transfusions: new aspects and perspectives
.
AUTHORS:
Spahn DR and Casutt M.
SOURCE:
Anesthesiology 2000;93:242-55
No abstract available
|
|
|
|